Pulmonary hypertension (PH) is high blood pressure in the arteries that carry blood from the heart to the lungs. It makes the heart work harder with every beat, and over time it can cause breathlessness, overwhelming fatigue, chest pain, and fainting — symptoms that often appear during ordinary activities like climbing stairs or carrying groceries. PH takes several forms, including pulmonary arterial hypertension (PAH, where the small arteries themselves narrow and stiffen) and chronic thromboembolic pulmonary hypertension (CTEPH, caused by old blood clots that never fully dissolved). A 2022 meta-analysis pooling data from 2,161 patients across 24 studies found that the psychological toll of living with PH is substantial — far beyond what the general population experiences. If breathlessness has come with a quiet undercurrent of worry or sadness, you are far from alone, and real support exists.
A Disease That's Often Missed at First
PH is rare and its early symptoms — breathlessness, fatigue, reduced stamina — overlap heavily with far more common conditions like asthma, deconditioning, or anxiety itself. Confirming a diagnosis usually requires a right-heart catheterization, a specialized test that isn't the first thing most doctors reach for. Many people spend a meaningful stretch of time with symptoms that are downplayed or attributed to something else before PH is identified, a pattern familiar to anyone who has experienced medical gaslighting. A 2022 systematic review and meta-analysis set out to measure, across the largest combined patient sample yet assembled, just how much depression and anxiety accompany this condition once diagnosed.
What the Research Found
- Depression affects more than 1 in 4 people with PH. Pooling 24 studies and 2,161 patients, researchers found a pooled depression prevalence of 28.0% (95% CI 20.5–36.8%) — measured using validated screening tools across the combined sample.
- Anxiety affects more than 1 in 3. The same meta-analysis found a pooled anxiety prevalence of 37.1% (95% CI 28.7–46.4%), making anxiety the more common of the two conditions in PH.
- Both figures dwarf general-population and even heart-failure rates. The study's authors compared their findings to WHO general-population estimates of 7.1% depression and 3.8% anxiety, and to heart-failure patients specifically (21.5% depression, 30% anxiety) — PH prevalence exceeded both benchmarks.
- Certain PH subtypes carry extra psychological risk. Pulmonary arterial hypertension linked to congenital heart disease (PAH-CHD) was associated with significantly higher odds of both depression (OR 1.68) and anxiety (OR 1.63), while chronic thromboembolic PH (CTEPH) was linked to higher odds of depression specifically (OR 1.18).
- Worse hemodynamic severity tracked with more anxiety. In the meta-regression, worse pulmonary vascular resistance and a lower (worse) cardiac index — both objective measures of how hard the heart is struggling — independently predicted higher anxiety, suggesting the psychological burden rises alongside the physical one.
You're Not Imagining How Heavy This Feels
A separate 2025 study from Japan looked specifically at how depression and anxiety differ between PH subtypes, assessing 234 patients with validated questionnaires. It found depression in 18% and anxiety in 19% of people with PAH, compared with a notably higher 27% depression and 30% anxiety among people with CTEPH. In the PAH group, depression was significantly linked to objectively worse disease — higher right atrial pressure, higher pulmonary vascular resistance, and lower blood oxygen saturation — echoing the larger meta-analysis's own finding that harder-working hearts and lungs go hand in hand with heavier emotional strain. Interestingly, anxiety in that same study showed no significant link to any hemodynamic measure, a reminder that fear and worry don't always move in lockstep with disease severity the way depression can. The meta-analysis also found striking regional variation in reported anxiety — around 61% in Asian cohorts versus 40% in European and 23% in North American ones — which its authors believe likely reflects differences in how anxiety is reported, recognized, and stigmatized across cultures rather than a true difference in who is suffering. If the physical unpredictability of PH is wearing on you day to day, our page on living with chronic illness or pain has additional tools that may help alongside what's here.
Getting the Right Kind of Help
Treatment guidance in this research is nuanced in an important way: SSRIs, often the first medication doctors reach for in depression, have specifically been linked to increased mortality risk and greater clinical worsening in people with PAH, likely because of how they interact with the same serotonin pathways involved in the disease itself. This isn't a reason to leave depression or anxiety untreated — it's a reason to pursue treatment in close partnership with your PH specialist rather than a generic prescription, so that any medication choice accounts for your specific cardiopulmonary status. For moderate-to-severe symptoms, cognitive behavioral therapy (CBT) is specifically recommended in clinical guidelines; for milder symptoms, psychotherapy alone is often a reasonable first step. Researchers are candid that rigorous studies testing these treatments specifically in PH patients remain scarce, so working with a care team willing to individualize your plan matters. Because PH is a progressive, life-limiting condition even with modern therapies, many people also carry a quiet fear of what's ahead; our page on coping with death anxiety offers tools built specifically for that fear, and our page on heart attacks and mental health covers related ground for anyone navigating cardiac-adjacent diagnoses alongside PH.
Ways to Cope
- Push for a prompt, specific diagnosis if your symptoms aren't adding up. If breathlessness and fatigue are dismissed as deconditioning or anxiety without a clear explanation, ask directly about pulmonary hypertension and request referral to a specialist — catching it earlier can change both your physical and emotional trajectory.
- Bring up mood symptoms at every PH appointment, not just physical ones. Given how common depression and anxiety are in PH, mentioning low mood or persistent worry to your cardiopulmonary team is reasonable and expected, not a distraction from your "real" care.
- Ask specifically about PH-aware mental health treatment. Given the SSRI safety nuance in PAH, seek a psychiatrist or therapist willing to coordinate with your PH specialist, or at minimum raise any new psychiatric medication with your cardiopulmonary team before starting it.
- Track your symptoms and your mood side by side. Because anxiety and depression in PH often (though not always) rise and fall with physical severity, a simple log of breathlessness, fatigue, and mood can help you and your care team spot patterns and intervene earlier.
- Connect with others who understand PH specifically. Pulmonary hypertension patient organizations and support groups can reduce the isolation of a rare disease, offering both practical coping strategies and the relief of being understood without having to explain everything from scratch.